Abstract
AbstractLymphatic filariasis and onchocerciasis are neglected tropical diseases (NTDs) targeted for elimination by mass (antifilarial) drug administration. These drugs are predominantly active against the microfilarial progeny of adult worms. New drugs or combinations are needed to improve patient therapy and to enhance the effectiveness of interventions in persistent hotspots of transmission. Several therapies and regimens are currently in (pre-)clinical testing. Clinical trial simulators (CTSs) project patient outcomes to inform the design of clinical trials but have not been widely applied to NTDs, where their resource-saving payoffs could be highly beneficial. We demonstrate the utility of CTSs using our individual-based onchocerciasis transmission model (EPIONCHO-IBM) that projects trial outcomes of a hypothetical macrofilaricidal drug. We identify key design decisions that influence the power of clinical trials, including participant eligibility criteria and post-treatment follow-up times for measuring infection indicators. We discuss how CTSs help to inform target product profiles.
Funder
Bill and Melinda Gates Foundation
Drugs for Neglected Diseases initiative
RCUK | Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference81 articles.
1. African Programme for Onchocerciasis Control. Eighteenth Session of the Joint Action Forum, http://www.who.int/apoc/about/structure/jaf/Final_Communique_JAF_18_English_final_with_annexes.pdf (2012).
2. World Health Organization. Accelerating work to overcome the global impact of neglected tropical 13. diseases – a roadmap for implementation executive summary (World Health Organization, Geneva, Switzerland, 2012).
3. Pion, S. D. S. et al. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo. Lancet Infect. Dis. 17, 763–769 (2017).
4. King, C. L. et al. A trial of a triple-drug treatment for lymphatic filariasis. N. Engl. J. Med. 379, 1801–1810 (2018).
5. World Health Organization. Progress report on the elimination of human onchocerciasis, 2017-2018. Wkly. Epidemiol. Rec. 47, 633–648 (2018).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献